Is l-Carnitine Supplementation Beneficial in 3-Methylcrotonyl-CoA Carboxylase Deficiency?
Open Access
- 1 January 2014
- book chapter
- Published by Springer Nature
- Vol. 21, 79-88
Abstract
Background: 3-Methylcrotonyl-CoA carboxylase deficiency (3-MCCd) is an autosomal recessive disorder in the catabolism of leucine. In the present study, we investigated the current and prior medical condition of patients with 3-MCCd in the Faroe Islands and their carnitine levels in blood, urine and muscle tissue with and without l-carnitine supplementation to evaluate the current treatment strategy of not recommending l-carnitine supplementation to Faroese 3-MCCd patients. Methods: Blood and urine samples and muscle biopsies were collected from patients at inclusion and at 3 months. Eight patients received l-carnitine supplementation when recruited; five did not. Included patients who received supplementation were asked to stop l-carnitine, the others were asked to initiate l-carnitine supplementation during the study. Symptoms were determined by review of hospital medical records and questionnaires answered at baseline and after the intervention. Results: The prevalence of 3-MCCd in the Faroe Islands was 1:2,400, the highest reported worldwide. All patients were homozygous for the MCCC1 mutation c.1526delG. When not administered l-carnitine, the 3-MCCd patients (n = 13) had low plasma and muscle free carnitine levels, 6.9 (SD 1.4) μmol/L and 785 (SD 301) nmol/g wet weight, respectively. l-Carnitine supplementation increased muscle and plasma carnitine levels to a low-normal range, 25.5 (SD 10.9) μmol/L and 1,827 (SD 523) nmol/g wet weight, p < 0.01, respectively. Seven of the thirteen 3-MCCd subjects suffered from self-reported fatigue with some alleviation after l-carnitine supplementation. Conclusion: 3-MCCd is common in the Faroe Islands. Some symptomatic 3-MCCd patients may benefit biochemically and clinically from l-carnitine supplementation, a more general recommendation cannot be given.Keywords
This publication has 28 references indexed in Scilit:
- Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe IslandsJournal of Inherited Metabolic Disease, 2013
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- 3-methylcrotonyl-CoA carboxylase deficiency: Clinical, biochemical, enzymatic and molecular studies in 88 individualsOrphanet Journal of Rare Diseases, 2012
- Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac eventsJournal of Inherited Metabolic Disease, 2012
- Treatment recommendations in long‐chain fatty acid oxidation defects: consensus from a workshopJournal of Inherited Metabolic Disease, 2009
- 3-Methylcrotonyl-CoA Carboxylase Deficiency: Phenotypic Variability in a FamilyJournal of Child Neurology, 2009
- Recurrent attacks of status epilepticus as predominant symptom in 3-methylcrotonyl-CoA carboxylase deficiencyBrain and Development, 2008
- Biochemical findings in common inborn errors of metabolismAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2006
- Consanguineous 3‐methylcrotonyl‐CoA carboxylase deficiency: Early‐onset necrotizing encephalopathy with lethal outcomeJournal of Inherited Metabolic Disease, 2005
- Linkage disequilibrium and demographic history of the isolated population of the Faroe IslandsEuropean Journal of Human Genetics, 2002